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ABSTRACT 22 
Background & Aims 23 
The incidence of osteoporotic fractures is lower in countries in the Mediterranean basin. Virgin 24 
olive oil, a key component of the Mediterranean Diet (MDiet), with recognised beneficial 25 
effects on metabolism and cardiovascular health, may decrease the risk of osteoporotic 26 
fractures. The aim to this study was to explore the effect of chronic consumption of total olive 27 
oil and its varieties on the risk of osteoporosis-related fractures in a middle-aged and elderly 28 
Mediterranean population.  29 
Methods. 30 
We included all participants (n=870) recruited in the Reus (Spain) centre of the PREvención 31 
con DIeta MEDiterránea (PREDIMED) trial. Individuals, aged 55-80 years at high 32 
cardiovascular risk, were randomized to a MedDiet supplemented with extra-virgin olive oil, a 33 
MedDiet supplemented with nuts, or a low-fat diet. The present analysis was an observational 34 
cohort study nested in the trial. A validated food frequency questionnaire was used to assess 35 
dietary habits and olive oil consumption. Information on total osteoporotic fractures was 36 
obtained from a systematic review of medical records. The association between yearly repeated 37 
measurements of olive oil consumption and fracture risk was assessed by multivariate Cox 38 
proportional hazards. 39 
Results. 40 
 We documented 114 incident cases of osteoporosis-related fractures during a median follow-up 41 
of 8.9 years. Treatment allocation had no effect on fracture risk.  Participants in the highest 42 
tertile of extra-virgin olive oil consumption had a 51% lower risk of fractures (HR:0.49; 95% 43 
CI:0.29-0.81. P for trend = 0.004) compared to those in the lowest tertile after adjusting for 44 
potential confounders. Total and common olive oil consumption was not associated with 45 
fracture risk.  46 
Conclusions. 47 
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Higher consumption of extra-virgin olive oil is associated with a lower risk of osteoporosis-48 
related fractures in middle-aged and elderly Mediterranean population at high cardiovascular 49 
risk.  50 
 51 
Keywords: Olive oil, Osteoporotic fractures, Prevention, Aging. 52 
 53 
Abbreviations: MedDiet, Mediterranean diet; BMD, bone mineral density; MUFA, 54 
monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; EVOO, extra virgin olive oil; 55 
FFQ, food frequency questionnaire; BMI, body mass index. 56 
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INTRODUCTION 57 
Osteoporosis is an age-related progressive bone condition characterised by bone mass loss and 58 
microarchitecture degradation that increase the risk of potentially serious fractures. It is a major 59 
burden for health care systems as osteoporotic fractures and falls by osteoporotic fractures are 60 
associated with a high dependence, morbidity and mortality.[1–3] Osteoporosis is estimated to 61 
affect 27.5 million people (22 million women and 5.5 million men) aged between 50-84 years 62 
worldwide and its prevalence is expected to rise to 33.9 million by 2025.[4]  63 
Bone remodeling balance is affected by several factors, such as age, heredity or endocrine 64 
diseases.[3] Lifestyle factors, such as smoking, physical activity and diet also affect bone 65 
health.[5] Low calcium intake and low exposure to sunlight leading to reduced synthesis of 66 
vitamin D have also been identified as common risk factors because of their role in bone mass 67 
health.[1,6] In addition, other specific nutrients, foods, or dietary patterns can influence bone 68 
health.[6–9] Adhering to a traditional Mediterranean diet (MedDiet), characterized by high 69 
intake of fruits, vegetables, nuts and olive oil, has been linked to a lower risk of hip 70 
fractures,[10–12] which might partly explain the epidemiological evidence of a geographical 71 
variation in the incidence of hip fractures across Europe, the highest rates being in North Europe 72 
and the lowest in the Mediterranean basin countries or in United States’ population where it was 73 
associated a lower risk of hip fracture with MedDiet pattern.[11,13] These observations might 74 
be attributed to the high content of monounsaturated fats (MUFA) and polyphenols in olive oil, 75 
the main fat consumed in the Mediterranean diet. The intake of MUFA has been positively 76 
correlated with bone mineral density (BMD) in the Greek and Spanish populations[14–16] and 77 
higher circulating levels of bone remodelling osteocalcin have been reported after following a 78 
MedDiet enriched with extra-virgin olive oil (EVOO).[17] Similarly, a high intake of olive 79 
extract has also been linked to higher levels of osteocalcin and stabilization of bone mass loss in 80 
osteopenic postmenopausal women.[18] 81 
The effect of consumption of olive oil and its varieties on the risk of osteoporotic fractures has 82 
not been studied. Our aim was to examine the association between the amount of total olive oil 83 
and its varieties (extra virgin and common olive oil) consumed and the risk of osteoporotic 84 
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fractures in a sub-sample of middle-aged and elderly Mediterranean participants of the 85 
PREDIMED trial. We hypothesized that higher consumption of EVOO containing high amounts 86 
of polyphenols would reduce the risk of osteoporosis-related fractures. 87 
MATERIALS AND METHODS. 88 
Study design and population. 89 
The present study was carried out in the framework of the PREDIMED study, a large, multi-90 
centre, randomized and controlled parallel group trial aimed at assessing the effect of the 91 
MedDiet on the primary prevention of cardiovascular diseases in Spain. This trial is registered 92 
at http://www.controlled-trials.com as ISRCTN35739639. Osteoporotic fractures were assessed 93 
only as part of an ancillary study including all participants (n=870) recruited in the 94 
PREDIMED-Reus centre. Full details of the PREDIMED protocol are published elsewhere.[19] 95 
Participants (men aged 55–80 years and women aged 60–80 years) were randomly assigned to 1 96 
of 3 intervention groups: (1) a MedDiet supplemented with EVOO (MedDiet-EVOO group; 50 97 
g or more per day), (2) a MedDiet supplemented with mixed nuts (MedDiet-Nuts; 30 g of nuts 98 
daily), or advice on a low-fat diet (Control). Supplemental foods were given for free to 99 
participants in the MedDiet groups, while those in the control diet group received non-food 100 
gifts. Participants had no history of CVD at baseline but they were at high cardiovascular risk 101 
because of the presence of type 2 diabetes or at least three of the following risk factors: current 102 
smoker; hypertension; high levels of low-density lipoprotein cholesterol; low levels of high-103 
density lipoprotein cholesterol; overweight or obesity and/or a family history of premature 104 
cardiovascular disease. Participants excluded were those with a BMI greater than 40 kg/m2, 105 
severe chronic illness, drug or alcohol addiction, history of allergy or intolerance to olive oil or 106 
nuts, and/or a low predicted likelihood of changing dietary habits according to Prochaska and 107 
DiClemente's stages-of-change model.[20] The local institutional review board approved the 108 
study protocol, and all participants provided written informed consent. Recruitment took place 109 
between 1st October, 2003, and 30th June, 2009 and the intervention was terminated in 2010 with 110 
an extended follow-up to August 2015. The study was performed according to Declaration of 111 
Helsinki about Ethical Principles for Medical Research Involving Human Subjects.   112 
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Measurements 113 
At baseline and at each annual visit until the end of intervention in 2010, data on lifestyle 114 
variables, medical conditions and medication use were recorded. Weight and height were 115 
measured with light clothing and no shoes, using calibrated scales and a wall-mounted 116 
stadiometer, respectively. Waist circumference was measured midway between the lowest rib 117 
and the iliac crest using an anthropometric tape. Blood pressure was measured using a validated 118 
oscillometer (Omron HEM705CP; Hoofddorp, The Netherlands) in triplicate with a five-minute 119 
interval between each measurement, and the mean of these values was recorded. Trained 120 
personnel took fasting blood samples for subsequent biochemical analysis. The validated 121 
Spanish version of the Minnesota Leisure-Time Physical Activity questionnaire was given at 122 
baseline and yearly.[21] 123 
Dietary assessment. 124 
A 137-item semi-quantitative validated food frequency questionnaire (FFQ) was given to all 125 
participants at baseline and was repeated every year throughout the follow-up period.[22] 126 
Energy and nutrient intake were estimated from Spanish food composition tables.[23,24] Data 127 
regarding the consumption of different types of olive oil was obtained from the FFQ, which 128 
included three different questions on the type of olive oil consumed: (1)   EVOO (obtained only 129 
by mechanically pressing the olives, acidity <1%), (2) refined oil (refined olive oil, acidity 130 
<0.3%) and (3) pomace olive oil (obtained using solvents from the leftovers of pressing the 131 
olives and mixed with other refined olive oils, acidity <0.3%). The number of 12 g tablespoons 132 
was recorded for each variety in 9 frequency categories as follows: no consumption, one to three 133 
times per month, n times per week (n = one, two to four or five to six) or n times per day (n = 134 
one, two to three, four to six or more than six). The number of tablespoons stated was converted 135 
into grams per day. One FFQ item asked about EVOO intake and two other items asked about 136 
refined olive oil and pomace olive oil, and these two values were added together for common 137 
olive oil intake. Total olive oil intake was then the sum of all three items. Using the Pearson 138 
correlation coefficient (r), reproducibility and validity of the FFQ were 0.55 and 0.60, 139 
respectively, for total olive oil consumption, and the intraclass correlation coefficients for 140 
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reproducibility and validity were 0.71 (P-value: <0.001) in a population similar to the 141 
PREDIMED participants.[22] 142 
A validated 14-item MedDiet screener was also administered to assess the degree of adherence 143 
to the MedDiet.[25] Two of the 14 items were related to olive oil intake. To control for the 144 
overall dietary pattern, the 2 items related to olive oil were removed from the total score; thus, a 145 
12-point score was used as covariate in the models. 146 
Outcome. 147 
All osteoporotic fractures were adjudicated according to the criteria defined by Warriner and co-148 
workers including fractures scoring over 5, representing those more likely due to osteoporosis 149 
This score consider fracture risk groups according to sex, age and race, and scored from 1 to 9 150 
with higher scores representing those fractures most likely due to osteoporosis.[26]  This was 151 
also selected in accordance with previous studies regarding new classification of osteoporotic 152 
fractures beyond the classical ones (vertebral, hip and wrist-forearm).[27–29]. According to the 153 
International Classification of Diseases Clinical Modification (ICD-CM), open clavicle (ICD-154 
CM 810.1-810.3), phalanges (ICD-CM 816.1-816.13 AND 826.0-826.1), tarsal/metatarsal 155 
(ICD-CM 825.0-825.39), scapula (ICD-CM 811.0-811.19), and skull/facial (ICD-CM 800.00-156 
804.99) fractures were excluded.[26] Incident cases of osteoporotic fractures through 1st 157 
December, 2010 were identified initially from a systematic, comprehensive and standardised 158 
annual review of all outpatient and inpatient medical records of each participant. Information on 159 
osteoporotic fractures was updated yearly using medical records. An independent researcher 160 
confirmed all fracture events.  161 
Statistical analyses. 162 
Participants’ baseline characteristics were described with means (SD) and percentages 163 
(number). To take advantage of the yearly dietary assessments, we averaged the food 164 
consumption from the baseline to the end of the follow-up or to the last follow-up FFQ before 165 
the occurrence of fractures. Then, participants were categorized into tertiles of total olive oil, 166 
EVOO or common olive oil consumption using the mean value of all FFQs from the beginning 167 
to the last before the incidence of fracture or the end of follow-up in those not suffering a 168 
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fracture. Dietary variables were adjusted for total energy intake using the residuals method[30] 169 
and they are presented in accordance with energy-adjusted tertiles of EVOO intake. Follow-up 170 
time was estimated as the interval from the beginning of the study up to the date of fracture 171 
events, death (for any reason) or end of follow-up, whichever came first.  172 
The associations between energy-adjusted tertiles of total olive oil consumption or its different 173 
subtypes and the risk of osteoporotic fractures were assessed using time-dependent multivariate 174 
Cox proportional hazards models. We tested the proportionality of hazards with the use log-rank 175 
test. Results are expressed as hazard ratios (HRs) and 95% confidence intervals (CI). Model 1 176 
was adjusted for age, sex, BMI, education level (primary education, secondary education, 177 
academic/graduate), leisure time physical activity (metabolic equivalent of task (MET)-178 
minutes/day), smoking status (never, former, current smoker) and the intervention group. As 179 
other covariates can interfere with the risk of fractures, Model 2 was additionally adjusted for 180 
prevalence of diabetes (yes/no), prevalence of previous documented osteoporotic fractures 181 
(yes/no), use of insulin (yes/no), use of oral antidiabetic medications (yes/no), use of diuretic 182 
drugs (yes/no), use of oral glucocorticoids (yes/no), use of anti-osteoporotic drugs (yes/no), use 183 
of anticoagulants (yes/no), use of oestrogen (yes/no) and baseline MedDiet adherence (12-point 184 
score). Covariates were selected based on their biological plausibility of having an association 185 
with the risk of fractures. The same models (excluding the baseline 12-point score) were used to 186 
assess the risk of osteoporotic fractures according to the dietary intervention group. The 187 
associations between MUFA intake, polyunsaturated fatty acids (PUFA) intake and 188 
MUFA:PUFA ratio with the risk of fractures were assessed using the covariates included into 189 
the Model 3. Nelson-Alen estimator was used to analyse the increasing failure rates.  Sensitivity 190 
analysis was conducted excluding early cases observed during the first year of intervention. The 191 
level of significance was P <0.05 for all statistical tests for bilateral contrast. Statistical analyses 192 
were carried using SPSS 21.0 for windows (IBM, Chicago, IL, USA) and STATA 14 193 
(StataCorp, College Station, TX). 194 
RESULTS. 195 
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During a median of 5.2 years of intervention and 8.9 years of follow-up, we documented 114 196 
incident cases of osteoporosis-related fractures (40 in MedDiet-EVOO group, 37 in MedDiet-197 
Nuts group and 37 in control group). Tables 1 and 2 show the baseline anthropometric and 198 
dietary characteristics of the study participants according to energy-adjusted tertiles of EVOO 199 
consumption. There were not significant differences in age, sex, BMI, previous fractures, 200 
prevalence of diabetes, medications, energy intake, protein intake, alcohol intake, vitamin D or 201 
fermented dairy products intake between tertiles of EVOO consumption. The mean 202 
consumption of total olive oil was 56.5 g/day in participants at the highest tertile and 37.6 g/day 203 
in those in the lowest tertile.  204 
According to the intervention group, no significant differences in the risk of osteoporotic 205 
fractures were observed (HR (95%CI)) 1.13 (0.71-1.79) and 1.05 (0.66-1.67) in the MedDiet-206 
EVOO and MedDiet-Nuts groups compared to control group (Supplemental file).  207 
Figure 1 shows the survival curve of osteoporotic fractures and the number of participants at 208 
risk by energy-adjusted EVOO tertiles at different time points. Table 3 shows the HR and 95% 209 
CIs for the association between total olive oil consumption and the specific subtypes and 210 
osteoporosis-related fractures. Total olive oil and common olive oil consumption were not 211 
associated with a lower risk of fractures despite a non-significant trend to a lower reduction of 212 
bone fracture risk was observed in subjects allocated in the highest tertiles of total olive oil 213 
consumption. In contrast, a 51% reduction in the risk of osteoporosis-related fractures was 214 
observed in the fully-adjusted model for individuals in the highest tertile of EVOO consumption 215 
compared to the reference tertile (HR: 0.49; 95% CI: 0.29 to 0.81). The highest tertile compared 216 
to the reference tertile of MUFA intake (HR: 1.04; 95% CI: 0.66 to 1.65), PUFA intake (HR: 217 
1.20; 95% CI: 0.76 to 1.90) or the MUFA:PUFA ratio (HR: 0.87; 95% CI: 0.55 to 1.38) showed 218 
no association with fracture risk.  219 
The results of the sensitivity analysis were consistent with the general analysis. When early 220 
cases occurred during the first year (7 events were excluded), the risk in the higher tertile of 221 
EVOO consumption was relatively 46% lower (HR: 0.54; 95% CI: 0.32 to 0.92, P for trend = 222 
0.050) than the reference tertile.  223 
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DISCUSSION 224 
The novel finding of this longitudinal study in an older Mediterranean population at high risk 225 
for cardiovascular disease is that high EVOO consumption is associated with a reduced risk of 226 
osteoporotic fractures, whereas a non-significant trend to a lower risk was also observed for 227 
total olive oil consumption.  228 
The prevalence of osteoporosis and osteoporosis-related fractures is highly variable within 229 
European regions, with the lowest prevalence in the Mediterranean area.[31] These differences 230 
might be attributed to environmental factors and dietary regimens.[10–12,32] The MedDiet is 231 
based on a combination of foods comprising a complex array of nutrients and bioactive 232 
phytochemicals with anti-inflammatory, antioxidant and alkalinising properties that could all 233 
contribute to bone health. Olive oil is one of the key foods in the MedDiet and its consumption 234 
accounts for one to two thirds of total vegetable fat intake, where MUFA, in the form of oleic 235 
acid, is the most abundant fatty acid consumed. In a cross-sectional study conducted in Greece, 236 
MUFA intake was associated with a higher BMD.[33] Another study conducted in adult Greek 237 
women found higher total and spine BMD in those whose diet contained a combination of olive 238 
oil and fish with little meat, but not in association with the full MedDiet pattern.[34] A higher 239 
dietary MUFA:PUFA ratio has also been related to a lower risk of osteoporotic-related fractures 240 
produced by a same-level fall in elderly subjects.[16]  241 
However, in the present study, we found no associations of MUFA intake or the MUFA:PUFA 242 
ratio with fracture risk. These differences might be due to our study population displaying 243 
narrow ranges of MUFA intake and the MUFA:PUFA ratio compared to previous studies. In 244 
fact, results from prior studies showed no significant protection against fractures from MUFA 245 
intake or MUFA:PUFA ratios in the ranges of our study population. Moreover, the differences 246 
in the risk of osteoporosis-related fractures between different types of olive oil observed in our 247 
study cannot be explained by differences in its fatty acid profile, as the fatty acid composition is 248 
not affected by the extraction method used, since all olive oils are produced from the same 249 
variety of olives.[35] This suggests that other compounds present in olive oil, beyond the fatty 250 
acid composition, might play an important role in bone health.  251 
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Common olive oil is a mixture of virgin and (usually) more than 80% of refined oil, with fewer 252 
antioxidant and anti-inflammatory compounds. In contrast, EVOO is the best quality oil, 253 
produced by mechanically pressing ripe olives, and contains the highest amounts of  bioactive 254 
and antioxidant components, such as polyphenols, that by different mechanisms might exert 255 
favourable effects on bone metabolism.[35] Several studies conducted in vitro and in animal 256 
models have assessed the beneficial role of olive oil phenols on the formation and maintenance 257 
of bone through its modulation of both bone cell differentiation and function.[36–38]  258 
Oleuropein, tyrosol and hydroxytyrosol, the most abundant polyphenols in olive oil, have been 259 
related to several beneficial effects on bone metabolism in vitro an in animal models.[39] In 260 
humans, osteopenic subjects who consumed 250 mg/day of a polyphenol extract from Olea 261 
europaea for 12 months significantly increased their osteocalcin levels and stabilized lumbar 262 
spine BMD compared to a control group.[18] Similarly, in a prior PREDIMED sub-study, we 263 
found higher serum levels of osteocalcin and the bone remodelling marker procollagen amino-264 
terminal pro-peptide after 2 years of intervention with the MedDiet-EVOO compared to 265 
theMedDiet-Nuts or the control diet.[17] In contrast, we found no significant protective effect 266 
on bone fractures in subjects allocated to the MedDiet-EVOO group compared to the control 267 
diet, as would be initially expected. This apparent discrepancy could be explained because the 268 
difference in the total consumption of either total olive oil or extra-virgin olive oil between 269 
participants in the MedDiet-EVOO group or control group was substantially lower than 270 
differences between tertiles of olive oil consumption, as participants had a high MedDiet score 271 
at baseline with olive oil as the main culinary fat. It is also plausible that exposure time to the 272 
intervention diets was not long enough to improve or delay the age-related changes in bone 273 
structure. Thus far, no other studies have been conducted to assess the relationship between 274 
olive oil consumption and bone-related markers. Our findings extend the potential beneficial 275 
role of EVOO consumption demonstrated on bone biochemical markers to a lower risk of 276 
osteoporotic-related fractures as clinical outcome. Moreover, our results also suggest a 277 
beneficial role of the phenolic compounds present in EVOO, as no association was found for the 278 
common refined olive oil, which is depleted of these bioactive compounds.   279 
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The strengths of our study are a well-characterized cohort with long-term follow-up, controlled 280 
by several potential confounders, the analysis of different varieties of olive oil and the use of 281 
cumulative mean across all the available FFQs to improve the precision of the exposure. For  282 
the fracture identification we used an objective score, however, this classification has some 283 
potential limitations as was based on fracture categories identified by standard diagnostic codes 284 
which identifies accurately a total of 94% of cases compared with the gold standard of medical 285 
record review.[26] There are also limitations to our study. First, the generalizability of our 286 
results may be limited, as the study population was made of older Mediterranean individuals at 287 
high cardiovascular risk which increased their risk for osteoporotic fractures.[40] Second, 288 
because of the observational nature of the study, residual confounding remains a possibility 289 
even though our analyses were extensively adjusted for a wide range of potential confounders. 290 
Third, no bone biochemical markers or data on BMD were available. Fourth, due to the low 291 
number of fractures and the relative small study size, we cannot exclude a potential beneficial 292 
effect of total olive oil consumption on the risk of bone fractures as the hazard ratio clearly 293 
indicates a lower risk, although not strong as for EVOO. Finally, although the FFQ used was 294 
validated, measurement errors cannot be discarded, especially regarding the self-reporting of 295 
different varieties of olive oil. Still, our findings are consistent with the potential beneficial 296 
effects of olive oil on bone health previously described. 297 
In summary, we found that greater consumption of EVOO is associated with a lower risk of 298 
osteoporosis-related fractures in an older Mediterranean population at high cardiovascular risk. 299 
Our findings highlight the consumption of EVOO, one of the key foods of the MedDiet, in the 300 
prevention of osteoporosis-related fractures.   301 
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Table 1. Baseline characteristics of study participants according to energy-adjusted tertiles of extra 
virgin olive oil consumption. 
Variable 
T1  
(n= 290) 
T2 
 (n= 290) 
T3  
(n= 290) 
Age (years)† 67 ± 6 68 ± 6 67 ± 6 
Men, % (n) 46.6 (135) 42.1 (122) 45.9 (133) 
BMI (kg/m2)† 29.7 ± 3.2 29.5 ± 3.2 29.6 ± 3.4 
Waist circumference (cm)† 101.9 ± 9.00 100.6 ± 8.3 101.1 ± 9.1 
Leisure-time energy expenditure  
255.1 ± 265.8 286.3 ± 281.3 244.2 ± 239.8 
in physical activity (MET minutes/day)† 
Smoking status, % (never, current, 
former) 
59.3, 12.8, 27.9  61.7, 14.1, 24.2 64.8, 9.3, 25.9 
Educational level, % (n)    
Primary education 5.9 (17) 6.6 (19) 6.6 (19) 
Secondary education 14.5 (42) 18.3 (53) 20.0 (58) 
Academic/graduate 79.6 (231) 75.2 (218) 73.4 (213) 
History of osteoporotic fractures, % (n) 18.3 (53) 14.5 (42) 19.3 (56) 
Diabetes, % (n) 51.0 (148) 49.3 (143) 55.5 (161) 
Hypertension, % (n) 85.2 (247) 86.2 (250) 85.5 (248) 
Medication use, % (n)    
Diuretics  26.9 (78) 23.8 (69) 23.8 (69) 
Insulin  5.2 (15) 5.9 (17) 6.6 (19) 
Oral glucocorticoids  1.4 (4) 1.0 (3) 1.7 (5) 
Osteoporosis drugs  9.7 (28) 11.0 (32) 13.1 (38) 
Oral anticoagulants  1.4 (4) 1.4 (4) 0.3 (1) 
Oral antidiabetic drugs  36.2 (105) 30.3 (88) 37.2 (108) 
Oestrogens 1.7 (5) 2.8 (8) 2.4 (7) 
† Data are expressed as means ± SD. BMI, body mass index; MET, Metabolic Equivalent of Task. 
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Table 2. Baseline dietary characteristics of study participants according to energy-adjusted tertiles of 
extra virgin olive oil consumption 
Variable 
T1 
(n=290) 
T2 
(n=290) 
T3 
(n=290) 
Nutrients    
Total energy intake (kcal/day)† 2314.3 ± 625.2 2327.2 ± 580.7 2291.5 ± 571.6 
Proteins (g/day)† 95.1 ± 21.8 96.3 ± 22.5 93.2 ± 22.4 
Carbohydrates (g/day)† 240.9 ± 79.5 234.3 ± 73.4 219.7 ± 67.0 
Total fat (g/day)† 100.4 ± 30.2 105.0 ± 30.1 108.9 ± 30.5 
Saturated fatty acids (g/day)† 26.9 ± 9.3 27.8 ± 9.3 27.5 ± 9.4 
Monounsaturated fatty acids (g/day)† 48.5 ± 15.8 52.4 ± 16.2 56.4 ± 15.9 
Polyunsaturated fatty acids (g/day)† 16.7 ± 6.8 16.5 ± 5.9 16.4 ± 6.1 
Fibre (g/day)† 22.6 ± 6.9 24.1 ± 8.5 23.6 ± 7.6 
Alcohol (g/day)† 9.5 ± 14.9 8.5 ± 13.6 8.4 ± 12.6 
Vitamin D (µg/day)† 5.8 ± 3.4 6.0 ± 3.6 5.7 ± 3.1 
Calcium (mg/day)† 1044.6 ± 362.7 1051.3 ± 364.4 992.3 ± 341.7 
Food    
Total olive oil (g/day)† 34.9 ± 16.9 40.8 ± 17.6 48.0 ± 15.9 
Extra virgin olive oil (g/day)† 20.0 ± 19.0 35.2 ± 19.2 46.3 ± 17.3 
Common olive oil (g/day)† 14.8 ± 19.4 5.3 ± 12.7 1.5 ± 6.1 
Legumes (g/day)† 17.7 ± 8.0 18.1 ± 9.2 17.4 ± 8.5 
Vegetables (g/day)† 284.7 ± 116.3 313.2 ± 137.0 322.1 ± 134.9  
Cereals (g/day)† 256.6 ± 101.7 254.0 ± 98.0 238.1 ± 90.4 
Fruit (g/day)† 299.5 ± 178.0 315.6 ± 177.2 319.3 ± 160.7 
No fermented dairy (g/day)† 274.83 ± 186.98  258.26 ± 186.93  234.96 ± 173.84  
Fermented dairy (g/day)† 114.66 ± 96.61 113.54 ± 95.39 105.29 ± 89.80 
Meat (g/day)† 142.7 ± 54.9 146.6 ± 55.7 146.3 ± 65.5 
Fish (g/day)† 101.0 ± 42.0 103.3 ± 45.6 102.1 ± 42.8 
Nuts (g/day)† 10.7 ± 12.6 14.3 ± 14.9 13.6 ± 15.5 
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Modified MedDiet score (12-point score) 6.4 ± 1.6 6.6 ± 1.8 6.6 ± 1.7 
† Data are expressed as means ± SD. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
23 
 
Table 3. Risk of osteoporotic fracture according to energy-adjusted tertiles of cumulative olive oil intake 
  
T1 
 (n = 290) 
T2  
(n = 290) 
T3  
 (n = 290) P for trend 
Mean total olive oil intake (g/day) 37.60 ± 6.76 48.23 ± 1.99 56.52 ± 4.32 
Fracture event, % (n) 13.80 (40) 13.80 (40) 11.70 (34) 
Mean total energy intake (kcal/day) 2240.19 ± 450.80 2254.16 ± 354.91 2236.28 ± 361.21  
Crude model 1 (Ref.) 0.93 (0.60, 1.44) 0.81 (0.51, 1.27) 0.367 
Multivariate model 1ᵃ  1 (Ref.) 0.78 (0.49, 1.23) 0.73 (0.45, 1.19) 0.202 
Multivariate model 2ᵇ 1 (Ref.) 0.74 (0.47, 1.18) 0.69 (0.42, 1.14) 0.141 
Mean common olive oil intake 
(g/day) -0.13 ± 0.12 0.63 ± 0.85 12.49 ± 8.90 
Mean total energy intake (kcal/day) 2000.56 ± 209.33 2516.34 ± 352.67 2213.73 ± 396.01  
Fracture event, % (n) 15.90 (46) 10.30 (30) 13.10 (38) 
Crude model 1 (Ref.) 0.63 (0.40, 1.00) 0.81 (0.53, 1.25) 0.950 
Multivariate model 1ᵃ  1 (Ref.) 0.88 (0.54, 1.42) 0.94 (0.61, 1.46) 0.955 
Multivariate model 2ᵇ 1 (Ref.) 0.96 (0.59, 1.56) 1.00 (0.64, 1.55) 0.952 
Mean extra-virgin olive oil intake 
(g/day) 28.77 ± 10.27 45.11 ± 2.99 55.35 ± 4.62 
Mean total energy intake (kcal/day) 2229.47 ± 446.80 2254.69 ± 352.28 2246.47 ± 368.47  
Fracture event, % (n) 15.90 (46) 12.80 (37) 10.70 (31) 
Crude model 1 (Ref.) 0.73 (0.48, 1.13) 0.63 (0.40, 0.99) 0.037 
Multivariate model 1ᵃ  1 (Ref.) 0.62 (0.39, 0.97) 0.52 (0.31, 0.85) 0.007 
Multivariate model 2ᵇ 1 (Ref.) 0.59 (0.37, 0.95) 0.49 (0.29, 0.81) 0.004 
Cox regression models were used to evaluate the risk of osteoporotic fracture event by energy-adjusted tertiles of 
total olive oil (g/day), energy-adjusted tertiles of common olive oil (g/day) and energy-adjusted tertiles extra-
virgin olive oil (g/day). Results were expressed as Hazard Ratios (95% CI) and means ± SD or percentage (n). 
ᵃ Model: Adjusted for age (years), sex, body mass index (BMI) (kg/m²), educational level (illiterate/primary 
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education, secondary education, academic /graduate), leisure time physical activity (Metabolic Equivalent of Task 
(MET)-minutes/day), the intervention group and smoking status (never, former, current smoker). 
ᵇ Model: Additionally adjusted for prevalence of diabetes (yes/no), prevalence of previous fractures (yes/no), use 
of insulin (yes/no), use of oral antidiabetic drugs (yes/no), use of diuretic drugs (yes/no), use of glucocorticoids 
drugs (yes/no), use of osteoporotic drugs (yes/no), use of anticoagulant drugs (yes/no), use of estrogen drugs 
(yes/no) and baseline Mediterranean diet adherence (12-point score). 
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Figure 1. Nelson-Aalen curves of cumulative hazard for osteoporotic fracture by tertiles 466 
of energy adjusted extra-virgin olive oil intake. 467 
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